Fibrinogen gamma gene 3′-end polymorphisms and risk of venous thromboembolism in the African-American and Caucasian population

Thrombosis and Haemostasis

Volumn 101, Issue 6, 2009, Pages 1078-1084

  Uitte De Willige, Shirley ^a   Pyle, Meridith E ^b   Vos, Hans L ^a   De Visser, Marieke C H ^a   Lally, Cathy ^c   Dowling, Nicole F ^b   Hooper, W Craig ^b   Bertina, Rogier M ^a   Austin, Harland ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

African Americans; Fibrinogen gamma; Polymorphisms; Risk; Venous thromboembolism

Indexed keywords

FIBRINOGEN; FIBRINOGEN GAMMA; UNCLASSIFIED DRUG; FIBRINOGEN VARIANT;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNICITY; FEMALE; FIBRINOGEN GAMMA GENE; GENE; GENE FREQUENCY; GENE SEQUENCE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK FACTOR; VENOUS THROMBOEMBOLISM; ADOLESCENT; DNA FLANKING REGION; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

3' FLANKING REGION; ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; DNA MUTATIONAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FIBRINOGENS, ABNORMAL; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 67049155332     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-12-0813     Document Type: Article

References (34)

1. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158: 585-593. (Pubitemid 28144815)
2. White RH, Zhou H, Romano PS. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med 1998; 128: 737-740. (Pubitemid 28204865)
3. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353: 1167-1173. (Pubitemid 29155221)
4. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67. (Pubitemid 24144355)
5. Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703. (Pubitemid 26383091)
6. Hooper WC, Dilley A, Ribeiro MJ, et al. A racial difference in the prevalence of the Arg506 - >Gln mutation. Thromb Res 1996; 81: 577-581. (Pubitemid 126352865)
7. Dilley A, Austin H, Hooper WC, et al. Prevalence of the prothrombin 20210 G-to-A variant in blacks: infants, patients with venous thrombosis, patients with myocardial infarction, and control subjects. J Lab Clin Med 1998; 132: 452-455. (Pubitemid 28564700)
8. Rees DC, Chapman NH, Webster MT, et al. Born to clot: the European burden. Br J Haematol 1999; 105: 564-566. (Pubitemid 29232189)
9. White RH, Zhou H, Murin S, et al. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 2005; 93: 298-305.
10. Dowling NF, Austin H, Dilley A, et al. The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE Study. J Thromb Haemost 2003; 1: 80-87.
11. Uitte de Willige S, de Visser MCH, Houwing-Duistermaat JJ, et al. Genetic variation in the fibrinogen gamma gene increases the risk of deep venous thrombosis by reducing plasma fibrinogen {gamma}' levels. Blood 2005; 106: 4176-4183. (Pubitemid 41775924)
12. Grunbacher G, Weger W, Marx-Neuhold E, et al. The fibrinogen gamma (FGG) 10034C>T polymorphism is associated with venous thrombosis. Thromb Res 2007; 121: 33-36. (Pubitemid 350026004)
13. Uitte de Willige S, Doggen CJM, de Visser MCH, et al. Haplotypes of the fibrinogen gamma gene do not affect the risk of myocardial infarction. J Thromb Haemost 2006; 4: 474-476.
14. Koch W, Hoppmann P, Biele J, et al. Fibrinogen genes and myocardial infarction - A haplotype analysis. Arterioscler Thromb Vasc Biol 2008; 28: 758-763. (Pubitemid 351651334)
15. Cheung EY, Uitte de Willige S, Vos HL, et al. Fibrinogen gamma' in ischemic stroke: a case-control study. Stroke 2008; 39: 1033-1035. (Pubitemid 351619556)
16. Uitte de Willige S, Rietveld IM, de Visser MC, et al. Polymorphism 10034C > T is located in a region regulating polyadenylation of FGG transcripts and influences the fibrinogen gamma'/gammaA mRNA ratio. J Thromb Haemost 2007; 5: 1243-1249. (Pubitemid 46902127)
17. Nickerson, D. SeattleSNPs. NHLBI Program for Genomic Applications, UW-FHCRC, Seattle, WA. http://pga.gs.washington.edu. 2003.
18. The International HapMap Project. Nature 2003; 426: 789-796.
19. Austin H, Key NS, Benson JM, et al. Sickle cell trait and the risk of venous thromboembolism among blacks. Blood 2007; 110: 908-912. (Pubitemid 47267428)
20. Livak KJ. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet Anal 1999; 14: 143-149. (Pubitemid 29095371)
21. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265. (Pubitemid 40202029)
22. Dilley A, Austin H, Hooper WC, et al. Relation of three genetic traits to venous thrombosis in an African- American population. Am J Epidemiol 1998; 147: 30-35. (Pubitemid 28034609)
23. Hooper WC, Lally C, Austin H, et al. The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans. Chest 1999; 116: 880-886. (Pubitemid 29491853)
24. Austin H, Hooper WC, Lally C, et al. Venous thrombosis in relation to fibrinogen and factor VII genes among African-Americans. J Clin Epidemiol 2000; 53: 997-1001. (Pubitemid 30750834)
25. Hooper WC, Lally C, Austin H, et al. The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African- American adults with a diagnosis of myocardial infarction or venous thromboembolism. Thromb Res 2000; 99: 223-230. (Pubitemid 30608700)
26. Hooper WC, Dowling NF, Wenger NK, et al. Relationship of venous thromboembolism and myocardial infarction with the renin-angiotensin system in African-Americans. Am J Hematol 2002; 70: 1-8. (Pubitemid 34461632)
27. Patel RK, Ford E, Thumpston J, et al. Risk factors for venous thrombosis in the black population. Thromb Haemost 2003; 90: 835-838. (Pubitemid 37427852)
28. Herrmann FH, Salazar-Sanchez L, Schuster G, et al. Prevalence of eight molecular markers associated with thrombotic diseases in six Amerindian tribes and two African groups of Costa Rica. Am J Hum Biol 2004; 16: 82-86. (Pubitemid 38100662)
29. Carter AM, Catto AJ, Kohler HP, et al. Alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism. Blood 2000; 96: 1177-1179. (Pubitemid 30616891)
30. Falls LA, Farrell DH. Resistance of gammaA/gamma' fibrin clots to fibrinolysis. J Biol Chem 1997; 272: 14251-14256. (Pubitemid 27232837)
31. Cooper AV, Standeven KF, Ariëns RA. Fibrinogen gamma-chain splice variant {gamma}' alters fibrin formation and structure. Blood 2003; 102: 535-540. (Pubitemid 36841972)
32. Standeven KF, Grant PJ, Carter AM, et al. Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function. Circulation 2003; 107: 2326-2330. (Pubitemid 36578503)
33. Sinha M, Larkin EK, Elston RC, et al. Self-reported race and genetic admixture. N Engl J Med 2006; 354: 421-422. (Pubitemid 43145081)
34. Mosesson MW, Hernandez I, Raife TJ, et al. Plasma fibrinogen gamma prime chain content in the thrombotic microangiopathy syndrome. J Thromb Haemost 2006; 5: 62-69.